Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Convertible Debt (2019 - 2024)

Bioadaptives' Convertible Debt history spans 6 years, with the latest figure at $311000.0 for Q3 2024.

  • For Q3 2024, Convertible Debt fell 4.5% year-over-year to $311000.0; the TTM value through Sep 2024 reached $311000.0, down 4.5%, while the annual FY2022 figure was $381793.0, 5.29% down from the prior year.
  • Convertible Debt for Q3 2024 was $311000.0 at Bioadaptives, roughly flat from $311000.0 in the prior quarter.
  • Across five years, Convertible Debt topped out at $446217.0 in Q3 2021 and bottomed at $311000.0 in Q2 2024.
  • The 5-year median for Convertible Debt is $352470.0 (2020), against an average of $367914.1.
  • The largest annual shift saw Convertible Debt surged 1822.39% in 2020 before it decreased 28.24% in 2023.
  • A 5-year view of Convertible Debt shows it stood at $405236.0 in 2020, then fell by 0.52% to $403117.0 in 2021, then dropped by 5.29% to $381793.0 in 2022, then dropped by 14.7% to $325671.0 in 2023, then decreased by 4.5% to $311000.0 in 2024.
  • Per Business Quant, the three most recent readings for BDPT's Convertible Debt are $311000.0 (Q3 2024), $311000.0 (Q2 2024), and $319403.0 (Q1 2024).